Ischemic preconditioning: Differences in protection and susceptibility to blockade with single-cycle versus multicycle transient ischemia

Circulation

Volumn 96, Issue 3, 1997, Pages 984-995

  Sandhu, Reena ^a,c,e   Diaz, Roberto J ^a   Mao, Guo D ^a   Wilson, Gregory J ^a,b,c,d  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Adrenergic; Alpha; Beta; Ischemia; Myocardial infarction; Receptors; Signal Transduction

Indexed keywords

6 (3 DIMETHYLAMINOPROPIONYL)FORSKOLIN; CHELERYTHRINE; CYCLIC AMP; POLYMYXIN B; PROTEIN KINASE C;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEMODYNAMICS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; RABBIT; REPERFUSION;

EID: 0030755563     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.3.984     Document Type: Article

References (40)

1. 1 adenosine receptors in rabbit heart. Circulation. 1991;84:350-356.
2. Liu Y, Downey J. Ischemic preconditioning protects against infarction in rat heart. Am J Physiol. 1992;263(4 pt 2):H1107-H1112.
3. Li G, Vasquez J, Gallagher K, Lucchesi B. Myocardial protection with preconditioning. Circulation. 1990;82:609-619.
4. Lawson C, Hearse D. Preconditioning and ischemia- and reperfusion-induced arrhythmias. In: Przyklenk K, Kloner R, Yellon D, eds. Ischemic Preconditioning: The Concept of Endogenous Cardioprotection. Norwell, Mass: Kluwer Academic Publishers; 1994:19-40.
5. Hagar J, Hale S, Kloner R. Effect of preconditioning ischemia on reperfusion arrhythmias after coronary artery occlusion and reperfusion in the rat. Circ Res. 1991;68:61-68.
6. 1-adrenergic mechanism. Circ Res. 1993;73:656-670.
7. Steenbergen C, Perlman M, London R, Murphy E. Mechanism of preconditioning: ionic alterations. Circ Res. 1993;72:112-125.
8. Walker D, Yellon D. Ischaemic preconditioning: from mechanisms to exploitation. Cardiovasc Res. 1992;26:734-739.
9. Jenkins D, Baxter G, Yellon D. The pathophysiology of ischemic preconditioning. Pharmacol Res. 1995;31:219-224.
10. Seyfarth M, Münch G, Schreieck J, Kurz T, Richardt G, Schömig A. Release of norepinephrine is suppressed by preconditioning in rat ischemic hearts. Circulation. 1994;90(suppl I):I-108. Abstract.
11. Sandhu R, Diaz R, Thomas U, Wilson G. Effect of ischemic preconditioning of the myocardium on cyclic AMP. Circ Res. 1996;78: 137-147.
12. Uchida T, Filburn CR. Affinity chromatography of protein kinase C-phorbol ester receptor on polyacrylamide-immobilized phosphatidylserine. J Biol Chem. 1984;259:12311-12314.
13. Al-Khayyat A, Aronson A. Pharmacologic and toxicologic studies with the polymyxins. Chemotherapy. 1973;19:82-97.
14. Hoeprich P. The polymyxins. Med Clin North Am. 1970;54: 1257-1265.
15. Miura T, Adachi T, Ogawa T, Iwamoto T, Tsuchida A, Iimura O. Myocardial infarct size: limiting effect of ischemic preconditioning: its natural decay and the effect of repetitive preconditioning. Cardiovasc Pathol. 1992;1:147-154.
16. Cave A, Collis C, Downey J, Hearse D. Improved functional recovery by ischaemic preconditioning is not mediated by adenosine in the globally ischaemic isolated rat heart. Cardiovasc Res. 1993;27:663-668.
17. Cave A, Apstein C. Inhibition of protein kinase C abolishes preconditioning against contractile dysfunction in the isolated blood perfused rat heart. Circulation. 1994;90(suppl I):I-206. Abstract.
18. Ytrehus K, Liu Y, Downey J. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol. 1994;266(3 pt 2):H1145-H1152.
19. Speechly-Dick M, Mocanu M, Yellon D. Protein kinase C: its role in ischemic preconditioning in the rat. Circ Res. 1994;75:586-590.
20. Mitchell M, Meng X, Ao L, Brown J, Harken A, Banerjee A. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ Res. 1995;76:73-81.
21. Bugge E, Ytrehus K. Ischaemic preconditioning is protein kinase C dependent but not through stimulation of alpha adrenergic or adenosine receptors in the isolated rat heart. Cardiovasc Res. 1995; 29:401-406.
22. Li Y, Kloner R. Does protein kinase C play a role in ischemic preconditioning in rat hearts? Am J Physiol. 1995;268(1 pt 2):H426-H431.
23. Liu Y, Cohen M, Downey J. Chelerythrine, a highly selective protein kinase C inhibitor, blocks the anti-infarct effect of ischemic preconditioning in rabbit hearts. Cardiovasc Drugs Ther. 1994;8: 881-882. Letter.
24. Herbert J, Augereau J, Maffrand J. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun. 1990;172:993-999.
25. Casnellie J. Protein kinase inhibitors: probes for PKC and the function of protein phosphorylation. Adv Pharmacol. 1991;22: 167-205.
26. Ward C, Moffat M. Role of protein kinase C in mediating effects of hydrogen peroxide in guinea-pig ventricular myocytes. J Mol Cell Cardiol. 1995;27:1089-1097.
27. Light P, Allen B, Walsh M, French R. Regulation of adenosine triphosphate-sensitive potassium channels from rabbit ventricular myocytes by protein kinase C and type 2A protein phosphatase. Biochemistry. 1995;34:7252-7257.
28. Serrano P, Rodriguez W, Pope B, Bennett E, Rosenzweig M. Protein kinase C inhibitor chelerythrine disrupts memory formation in chicks. Behav Neurosci. 1995;2:278-284.
29. Yashpal K, Pitcher G, Parent A, Quirion R, Coderre T. Noxious thermal and chemical stimulation induced increases in 3H-phorbol 12,13-dibutyrate binding in spinal cord dorsal horn as well as persistent pain and hyperalgesia, which is reduced by inhibition of protein kinase C. J Neurosci. 1995;15:3263-3272.
30. Glantz S. What does 'not significant' really mean? In: Kaufman B, White B, White J, eds. Primer of Biostatistics. 2nd ed. New York, NY: McGraw-Hill; 1987:138-159.
31. Tsien R. Calcium channels in excitable cell membranes. Annu Rev Physiol. 1983;45:341-358.
32. Opie L. Role of cyclic nucleotides in heart metabolism. Cardiovasc Res. 1982;16:483-507.
33. Katz A. Interplay between inotropic and lusitropic effects of cyclic adenosine monophosphate. Circulation. 1990;82(suppl I):I-7-I-11.
34. Simkhovich B, Hale S, Ovize M, Przyklenk K, Kloner R. Ischemic preconditioning and long-chain acyl carnitine in the canine heart. Coron Artery Dis. 1993;4:387-392.
35. Murry C, Richard V, Reimer K, Jennings R. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res. 1990;66:913-931.
36. Thornton J, Liu G, Downey J. Pretreatment with pertussis toxin blocks the protective effects of preconditioning: evidence for a G-protein mechanism. J Mol Cell Cardiol. 1993;25:311-320.
37. Brew E, Rehring T, Banerjec A. Bradykinin receptors mediate preconditioning through protein kinase C. Circulation. 1994; 90(suppl I):I-205. Abstract.
38. Watson S, Arkinstall S. The G-Protein Linked Receptor Facts Book. San Diego, Calif: Academic Press Ltd; 1994:7-18 and 19-31.
39. Murphy E, Glasgow W, Fralix T, Steenbergen C. Role of lipoxygenase metabolites in ischemic preconditioning. Circ Res. 1995;76:457-467.
40. Goto M, Liu Y, Yang X, Ardell J, Cohen M, Downey J. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res. 1995;77:611-621.